Fifteen medical sales representatives from Australian pharmaceutical companies received the industry's top accolade for ethical sales and marketing at a ceremony in Sydney last night.

The Medicines Australia Continuing Education Program Awards are presented annually to sales representatives who achieve maximum marks in their compulsory ethics education program.

Medicines Australia chief executive Dr Brendan Shaw said the mandatory program, developed by Medicines Australia and the University of Queensland, demonstrated the medicines industry's commitment to ethical conduct.

"The program is designed to ensure medical representatives are educated to a recognised industry standard to provide healthcare professionals with accurate and balanced information in an ethical manner," Dr Shaw said.

"I congratulate all students who completed the course and in particular this year's award winners.

"The fact that so many students achieved the highest possible marks signals the importance that students and companies attach to ethical conduct.

The Awards were presented by Australian Medical Association President Dr Andrew Pesce and, representing the University of Queensland's School of Pharmacy, Dr Harry Parekh.

The Medicines Australia Code of Conduct Award, for full marks in the Code of Conduct Program was presented to Paul Wilson (Janssen).

The Medicines Australia CEP Achievement Awards went to: Amy Beamish (AstraZeneca), Laura Boyd (Invida), Leonie Brown (Boehringer Ingelheim), Colin Clarke (AstraZeneca), Eritsa Cook (Servier), Michelle Dyson (Pfizer), Jonathan Koch (AstraZeneca), Pearl-Li Chong (MSD), Matthew Lisle (Novo Nordisk), Timothy Ludlow (GlaxoSmithKline), Lindsay Prodea (GlaxoSmithKline), Emma Rohrlach (Invida), Catherine Spencer (Amgen).

The UQ Health Insitu Active Learning Awards for the most active and best quality participation in online student group discussion were presented to Colin Clarke (AstraZeneca) and Deborah Motta-Marques (Allergan).

Source:
Medicines Australia